Auto-Injectors Market :- The rising incidence of anaphylaxis, increasing prevalence of multiple sclerosis, surging geriatric population, and rapid production of biologic products are the main factors pushing up the demand for auto-injectors across the world. In addition, the soaring healthcare spending in several countries and the growing public awareness about the various beneficial traits of auto-injectors are also contributing toward their booming sales. Auto-injectors are basically pen like medical instruments that are used for administering a specified dose of drugs into the body.
They consist of spring-loaded syringes that are particularly built for ensuring the safe administration of drugs into the body. These instruments have various added beneficial traits such as greater user-friendliness, which reduces the requirement for frequent visits to medical practitioners. Due to these factors, the popularity of these devices is growing rapidly, which is, in turn, driving the growth of the global auto-injectors market. Fillable and prefilled are the two major types of auto-injectors used across the world.
Between these, the demand for the prefilled auto-injectors market was observed to be higher during the last few years. In terms of manufacturing design, auto-injectors are classified into customized and standardized. Between these two, the sales of the standardized auto-injectors were found to be higher in the past years. This was because these injectors are built in a way so that they can be easily assembled and the self-administration process of drugs can be easily performed without modifying the primary packaging.
This is achieved by using automated pathways, that considerably reduce the chances of dose errors and accidental injuries. These devices are extensively used for treating multiple sclerosis, anaphylaxis, and rheumatoid arthritis. Out of these, the requirement for these devices was the highest in the treatment of anaphylaxis in the years gone by, as per the observations of the market research firm, P&S Intelligence. This was because of the widespread occurrence of this disease.
As per the World Allergy Organization (WAO), 0.6% to 1% of the Australian population, 0.1% of the Korean population, and 2% of the U.S. population suffer from anaphylaxis. Geographically, the sales of auto-injectors were the highest in North America during the past few years, with the U.S. registering the highest sales of these devices in the region. This was ascribed to the high incidence of anaphylaxis and diabetes and the existence of a large geriatric population in the region.
Europe also witnessed huge sales of these devices in the past years. In this continent, the demand for these products was the highest in the U.K., followed by Germany and France. On the other hand, the sales of these devices are predicted to soar in Asia-Pacific (APAC) in the forthcoming years, mainly because of the growing public awareness about the various needle-stick injuries in the region. The demand for auto-injectors will also surge in Europe in the years to come.
Thus, it can be said with certainty that the demand for auto-injectors will shoot up in the future, on account of the growing incidence of anaphylaxis and diabetes, the surging population of ageing people, and rising public awareness about safer drug administration methods across the world.
